BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36140218)

  • 21. Fenretinide Beneficial Effects on Amyotrophic Lateral Sclerosis-associated SOD1
    Orienti I; Armida M; Dobrowolny G; Pepponi R; Sollazzini G; Pezzola A; Casola I; Musarò A; Popoli P; Potenza RL
    Neuroscience; 2021 Oct; 473():1-12. PubMed ID: 34363869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis.
    Beers DR; Henkel JS; Xiao Q; Zhao W; Wang J; Yen AA; Siklos L; McKercher SR; Appel SH
    Proc Natl Acad Sci U S A; 2006 Oct; 103(43):16021-6. PubMed ID: 17043238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.
    Vaz AR; Pinto S; Ezequiel C; Cunha C; Carvalho LA; Moreira R; Brites D
    Front Cell Neurosci; 2019; 13():109. PubMed ID: 31024256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of neural and cell cycle-related microRNAs in brain of amyotrophic lateral sclerosis mice at late disease stage.
    Marcuzzo S; Bonanno S; Kapetis D; Barzago C; Cavalcante P; D'Alessandro S; Mantegazza R; Bernasconi P
    Mol Brain; 2015 Jan; 8():5. PubMed ID: 25626686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Almer G; Vukosavic S; Romero N; Przedborski S
    J Neurochem; 1999 Jun; 72(6):2415-25. PubMed ID: 10349851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous treatment for ALS with implication for broad neuroprotection.
    Kim D; Kim S; Sung A; Patel N; Wong N; Conboy MJ; Conboy IM
    Transl Neurodegener; 2022 Mar; 11(1):16. PubMed ID: 35272709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1
    Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M
    Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death.
    Martin LJ; Liu Z; Chen K; Price AC; Pan Y; Swaby JA; Golden WC
    J Comp Neurol; 2007 Jan; 500(1):20-46. PubMed ID: 17099894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model.
    Cui Y; Masaki K; Yamasaki R; Imamura S; Suzuki SO; Hayashi S; Sato S; Nagara Y; Kawamura MF; Kira J
    J Neuroinflammation; 2014 Mar; 11():42. PubMed ID: 24597481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-acetyl-L-tryptophan delays disease onset and extends survival in an amyotrophic lateral sclerosis transgenic mouse model.
    Li W; Fotinos A; Wu Q; Chen Y; Zhu Y; Baranov S; Tu Y; Zhou EW; Sinha B; Kristal BS; Wang X
    Neurobiol Dis; 2015 Aug; 80():93-103. PubMed ID: 25986728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing effects of microgravity and amyotrophic lateral sclerosis in the mouse ventral lumbar spinal cord.
    Yoshikawa M; Ishikawa C; Li H; Kudo T; Shiba D; Shirakawa M; Muratani M; Takahashi S; Aizawa S; Shiga T
    Mol Cell Neurosci; 2022 Jul; 121():103745. PubMed ID: 35660087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Axotomy-induced target disconnection promotes an additional death mechanism involved in motoneuron degeneration in amyotrophic lateral sclerosis transgenic mice.
    Haulcomb MM; Mesnard NA; Batka RJ; Alexander TD; Sanders VM; Jones KJ
    J Comp Neurol; 2014 Jul; 522(10):2349-76. PubMed ID: 24424947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1
    MacLean M; Juranek J; Cuddapah S; López-Díez R; Ruiz HH; Hu J; Frye L; Li H; Gugger PF; Schmidt AM
    J Neuroinflammation; 2021 Jun; 18(1):139. PubMed ID: 34130712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
    Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
    Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
    Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
    Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic Dental Pulp Stem Cell Secretome Therapy in a Mouse Model of Amyotrophic Lateral Sclerosis.
    Wang J; Zuzzio K; Walker CL
    Brain Sci; 2019 Jul; 9(7):. PubMed ID: 31337114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
    Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
    J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single injection of sustained-release prostacyclin analog ONO-1301-MS ameliorates hypoxic toxicity in the murine model of amyotrophic lateral sclerosis.
    Tada S; Okuno T; Shimizu M; Sakai Y; Sumi-Akamaru H; Kinoshita M; Yamashita K; Sanda E; Choong CJ; Namba A; Sasaki T; Koda T; Takata K; Miyagawa S; Sawa Y; Nakatsuji Y; Mochizuki H
    Sci Rep; 2019 Mar; 9(1):5252. PubMed ID: 30918303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.